VALVULAR AND STRUCTURAL HEART DISEASES

被引:9
|
作者
Cubeddu, Roberto J. [1 ,2 ]
Don, Creighton W. [2 ,3 ]
Horvath, Sofia A. [1 ]
Gupta, Pritha P. [2 ]
Cruz-Gonzalez, Ignacio [3 ]
Witzke, Christian [3 ]
Inglessis, Ignacio [3 ]
Palacios, Igor F. [3 ]
机构
[1] Aventura Hosp & Med Ctr, Miami, FL 33180 USA
[2] Univ Washington, Med Ctr, Div Cardiol, Seattle, WA 98195 USA
[3] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA
关键词
balloon aortic valvuloplasty; predictors; outcome LVEDP; TAVI; BALLOON AORTIC VALVULOPLASTY; END-DIASTOLIC PRESSURE; LONG-TERM SURVIVAL; FOLLOW-UP; EJECTION FRACTION; PREDICTORS; STENOSIS; DETERMINANTS; MORTALITY; FAILURE;
D O I
10.1002/ccd.24410
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectivesIn this study, we examined the predictive value of the left ventricular end-diastolic pressure (LVEDP) in patients undergoing balloon aortic valvuloplasty (BAV). BackgroundThe LVEDP is a useful indicator of hemodynamic status in patients with severe aortic stenosis. In BAV, decompensated heart failure is associated with worse outcomes. MethodsWe identified all consecutive patients with severe symptomatic aortic stenosis who underwent retrograde BAV at the Massachusetts General Hospital from 2004 to 2008. Patients were stratified and compared according to their baseline LVEDP into 15 mm Hg, 16-20 mm Hg, 21-25 mm Hg, and 26 mm Hg. Procedural and in-hospital outcomes and adverse events were compared. Multivariate logistic regression was used for the adjusted analysis. ResultsA total of 111 patients with a mean age of 8311 years underwent BAV. Of these, the LVEDP was 15 mm Hg in 29 (26%), 16-20 mm Hg in 41 (37%), 21-25 mm Hg in 16 (14%), and 26 mm Hg in 25 (23%) patients. Baseline characteristics were similar among the four groups. Noticeably, patients with high LVEDP levels had significantly higher rates of the combined endpoint of in-hospital death, myocardial infarction (MI), cardiopulmonary arrest, and tamponade was P = 0.02. Periprocedural MI was more common among those with higher LVEDP (16% vs. 2.3%; P = 0.04). Multivariate analysis revealed LVEDP (OR 1.08, for each mm Hg increase in pressure, 95 % CI 1.02-1.14), small LV chamber size, and New York Heart Association class as independent predictors of adverse outcomes. ConclusionsThe LVEDP is an important independent predictor of poor in-hospital outcome during BAV. In these patients, the immediate hemodynamic status may be more important than the baseline left ventricular systolic function. Hemodynamic optimization before or during BAV should be considered and may be beneficial. (c) 2012 Wiley Periodicals, Inc.
引用
收藏
页码:782 / 788
页数:7
相关论文
共 50 条
  • [31] Percutaneous structural and valvular heart disease interventions
    Vavalle, John P.
    Arora, Sameer
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2020, 10 (01) : 1 - 2
  • [32] Stress Echocardiography: the Role in Assessing Valvular Heart Diseases
    Raissi S.R.
    Kinno M.
    Rigolin V.H.
    Current Cardiovascular Imaging Reports, 2018, 11 (12)
  • [33] VALVULAR HEART DISEASES Management of asymptomatic mitral regurgitation
    Grigioni, Francesco
    Branzi, Angelo
    HEART, 2010, 96 (23) : 1938 - 1945
  • [34] Valvular heart diseases in patients treated for breast cancer
    Kushnareva, E.
    Moiseeva, O.
    ANNALS OF ONCOLOGY, 2020, 31 : S1376 - S1376
  • [35] Extracardiac causes of failure of compensation in valvular diseases of the heart
    Stengel, A
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1913, 145 : 17 - 28
  • [36] Valvular and coronary heart disease in systemic inflammatory diseases
    Roldan, Carlos A.
    HEART, 2008, 94 (08) : 1089 - 1101
  • [37] Concomitant surgical treatment of dental and valvular heart diseases
    Lockhart, Peter B.
    Brennan, Michael T.
    Cook, William H.
    Sasser, Howell
    Lovell, Roger D.
    Skipper, Eric R.
    Noll, Jenene
    Cox, Timothy L.
    Aten, Deborah J.
    Cook, Joseph W.
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2009, 107 (01): : 71 - 76
  • [38] Human heart valves ("homografts") for the treatment of valvular diseases
    Madershahian, N.
    Franke, U.
    Strauch, J.
    Wahlers, T.
    ZEITSCHRIFT FUR HERZ THORAX UND GEFASSCHIRURGIE, 2005, 19 (03): : 101 - 108
  • [39] VALVULAR HEART-DISEASES .10. MULTIVALVULAR HEART-DISEASES .2.
    STIERLE, U
    POTRATZ, J
    MEYER, D
    TARBIAT, S
    SHEIKHZADEH, A
    DIEDERICH, KW
    HERZ KREISLAUF, 1989, 21 (01): : 25 - &
  • [40] A nationwide contemporary epidemiological portrait of valvular heart diseases
    Clavel, Marie Annick
    Iung, Bernard
    Pibarot, Philippe
    HEART, 2017, 103 (21) : 1660 - 1662